Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07736261) titled 'Drospirenone-Primed Ovarian Stimulation Versus GnRH Antagonist Protocol in Poor Ovarian Responders Undergoing Freeze-All IVF/ICSI' on July 22.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).
Primary Sponsor: Ahmed Saad
Condition:
Poor Ovarian Reserve
Infertility (IVF Patients)
Intervention:
Drug: Drospirenone drug
Recruitment Status: Not recruiting
Phase: Phase 1/Phase 2
Date of First Enrollment: August 2026
Target Sample Size: 100
Countries of Recruitment:
Egypt
To know more, visi...